NASDAQ:GRFS
Grifols, S.A.
- Stock
locale
United Statesmarket
STOCKSindustry
Drug Manufacturers / Generalwebsite
www.grifols.comcrunchbase
www.crunchbase.com/acquisition/grifols-acquires-biotest-ag-2--26243280linkedin
grifolsfounding date
Jan 01, 1940ipo date
Jun 24, 2008
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus